Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Vivos Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 30 | 31 | +1 |
| Shares | 5.01M | 4.69M | −320.8K (−6.4%) |
| Value | $1.71M | $2.39M | +$681.0K (+39.8%) |
New holders (7)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 35,484 | $18.1K | 0.00% |
| Signaturefd, LLC | 13,671 | $6.97K | 0.00% |
| Two Sigma Securities, LLC | 12,387 | $6.32K | 0.00% |
| Advisor Group Holdings, Inc. | 1,000 | $510 | 0.00% |
| The PNC Financial Services Group, Inc. | 500 | $255 | 0.00% |
| Steward Partners Investment Advisory, LLC | 200 | $102 | 0.00% |
| Capital Advisors, Ltd. LLC | 185 | $0 | 0.00% |
Sold out (6)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bard Associates Inc | 201,704 | $68.8K |
| Millennium Management LLC | 19,118 | $7.00K |
| Wealth Alliance Advisory Group, LLC | 17,498 | $5.97K |
| FMR LLC | 3,600 | $1.23K |
| Stephens Consulting, LLC | 1,500 | $512 |
| Toth Financial Advisory Corp | 200 | $69 |